A grocery shopper at a Chicago store on Jan. 15. (Scott Olson/Getty Images) In the final days of the Biden administration, the Food and Drug Administration proposed a front-of-package food label ...
Wednesday, announced that the FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay for the treatment of endometrial cancer. The ACR-368-tailored OncoSignature assay is ...
Results that may be inaccessible to you are currently showing.